HAIRY CELL LEUKEMIA
Clinical trials for HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia: targeted pill shows promise in relapsed patients
Disease control OngoingThis study tests a pill called ibrutinib in 44 people whose hairy cell leukemia has returned after prior treatment. Ibrutinib blocks a protein that helps cancer cells grow. The main goal is to see how many patients achieve remission within 32 weeks, while also checking for side e…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Promising combo targets rare leukemia without prior treatment
Disease control OngoingThis study tests two drugs, vemurafenib (a pill) and obinutuzumab (an infusion), in 30 people with untreated hairy cell leukemia. The goal is to see if the combination can achieve a complete response, meaning no signs of cancer after treatment. Participants take vemurafenib for 4…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC